Protean Electric appoints new General Manager to drive China operations
- Dan Fang appointed to oversee the Protean team in China
- Fang brings with him over 17 years’ experience within the Chinese auto industry
- Appointment signals continued growth in China following acquisition by NEVS earlier this year
Farnham, UK – Automotive technology innovator, Protean Electric, has appointed Dan Fang as General Manager and Vice-President of Operations in China. Fang’s appointment will enable the leading technology company to further expand its operations in China, after it was acquired by National Electric Vehicle Sweden (NEVS), a subsidiary of Evergrande Health, in June this year. Responsible for all of Protean Electric’s operations in China, with a key focus on manufacturing, Fang will also help shape the future strategy of the business.
Fang brings extensive knowledge of the industry, having spent over 17 years managing leading automotive technology suppliers. Most recently, Fang was Vice President of Operations at Autoliv China, responsible for five production plants and devising the strategic direction for the company. Previously he held roles with NIO Electrical Powertrain in China, and with General Motors Production Center and Toyota Motor Manufacturing, both in Canada.
KY Chan, CEO of Protean Electric, commented: “Dan will play an important role at this exciting time in Protean’s growth in China and the team is looking forward to working with him. He will be responsible for further establishing Protean within the Chinese mobility market, leveraging his global experience and building on the growth and success we have seen in China over the past few years.”
Fang added, “Protean is a growing brand within the vibrant electric and mobility market in China and there is huge potential for us to establish our innovative technology as an industry benchmark. I am thrilled to have the opportunity to lead such a talented and well-respected team, and I look forward to working with my new colleagues to help realise the company’s full potential.”
Protean Electric is a world-leading developer of in-wheel motors (IWMs). Compared to conventional electrified powertrains, the highly-integrated ProteanDrive in-wheel motors offer improved powertrain efficiency and greater flexibility in vehicle design. The patented high-torque density ProteanDrive technology combines a direct drive electric motor and power electronics which can be utilised on a range of platforms, including passenger cars, light commercial vehicles, urban mobility vehicles and autonomous pods.
National Electric Vehicle Sweden (NEVS), a subsidiary of Evergrande Health, acquired Protean Electric in June 2019. The acquisition is part of Evergrande’s strategy to become a major player in the global electric vehicle (EV) industry and paves the way for NEVS to deploy ProteanDrive in-wheel motors into its future products. Protean Electric continues to operate as a standalone business under the Evergrande umbrella, developing future powertrain and mobility solutions to meet the needs of the market. The acquisition provides additional resources and business opportunities for Protean Electric, giving the company access to an even broader pool of skills, knowledge and experience, as well as a sizeable customer in NEVS.
Notes to editors
Saffron Johnson, PFPR Communications
+44 (0)1622 766510 / +44 (0)7515 060527 / email@example.com
About Protean Electric
Protean Electric is an automotive technology innovator, and a world-leading developer of in-wheel motors including ProteanDrive, a fully integrated in-wheel drive solution. Protean Electric’s technology is strategically positioned to play a major role in the hybrid, electric vehicle and future mobility market by offering a combination of packaging advantages, new vehicle design opportunities, performance benefits and earnings improvements. Globally Protean Electric has 160 patents across 75 patent families with operations in the United Kingdom, China and the USA. It is a subsidiary of National Electric Vehicle Sweden (NEVS) and part of Evergrande Health’s ‘New Energy Vehicle’ Group.
For more information, please visit www.proteanelectric.com